These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 11332558)

  • 1. Provoked and spontaneous high-frequency, low-amplitude, respirophasic noise transients in patients with implantable cardioverter defibrillators.
    Sweeney MO; Ellison KE; Shea JB; Newell JB
    J Cardiovasc Electrophysiol; 2001 Apr; 12(4):402-10. PubMed ID: 11332558
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oversensing during ventricular pacing in patients with a third-generation implantable cardioverter-defibrillator.
    Kelly PA; Mann DE; Damle RS; Reiter MJ
    J Am Coll Cardiol; 1994 Jun; 23(7):1531-4. PubMed ID: 8195509
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multicenter investigation of an implantable cardioverter-defibrillator algorithm to detect oversensing.
    Welte N; Strik M; Eschalier R; Mondoly P; Defaye P; Frontera A; Ritter P; Haïssaguerre M; Ploux S; Koneru J; Ellenbogen KA; Bordachar P
    Heart Rhythm; 2017 Jul; 14(7):1008-1015. PubMed ID: 28323174
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of bradycardia pacing caused by far-field atrial sensing in a third-generation cardioverter defibrillator with an automatic gain feature.
    Curwin JH; Roelke M; Ruskin JN
    Pacing Clin Electrophysiol; 1996 Jan; 19(1):124-6. PubMed ID: 8848369
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spatial and temporal heterogeneity of depolarization and repolarization may complicate implantable cardioverter defibrillator therapy in Brugada syndrome.
    Stix G; Bella PD; Carbucicchio C; Schmidinger H
    J Cardiovasc Electrophysiol; 2000 May; 11(5):516-21. PubMed ID: 10826930
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Experience with an implantable tiered therapy device incorporating antitachycardia pacing and cardioverter/defibrillator therapy.
    Mitchell JD; Lee R; Garan H; Ruskin JN; Torchiana DF; Vlahakes GJ
    J Thorac Cardiovasc Surg; 1993 Mar; 105(3):453-62; discussion 462-3. PubMed ID: 8445925
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Strategies to avoid inappropriate therapies due to ventricular double detection in biventricular pacing implantable cardioverter/defibrillators.
    Kolb C; Zrenner B; Schreieck J; Schmitt C
    Eur J Heart Fail; 2003 Aug; 5(4):523-6. PubMed ID: 12921814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppression of cautery-induced electromagnetic interference of cardiac implantable electrical devices by closely spaced bipolar sensing.
    Suresh M; Benditt DG; Gold B; Joshi GP; Lurie KG
    Anesth Analg; 2011 Jun; 112(6):1358-61. PubMed ID: 21543788
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of automatic multimodal device therapy for ventricular tachyarrhythmias as delivered by a new implantable pacing cardioverter-defibrillator. Results of a European multicenter study of 102 implants.
    Fromer M; Brachmann J; Block M; Siebels J; Hoffmann E; Almendral J; Ohm OJ; den Dulk K; Coumel P; Camm AJ
    Circulation; 1992 Aug; 86(2):363-74. PubMed ID: 1638705
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Eligibility of Pacemaker Patients for Subcutaneous Implantable Cardioverter Defibrillators.
    Ip JE; Wu MS; Kennel PJ; Thomas G; Liu CF; Cheung JW; Markowitz SM; Lerman BB
    J Cardiovasc Electrophysiol; 2017 May; 28(5):544-548. PubMed ID: 28185354
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intradevice interaction in a dual chamber implantable cardioverter defibrillator preventing ventricular tachyarrhythmia detection.
    Shivkumar K; Feliciano Z; Boyle NG; Wiener I
    J Cardiovasc Electrophysiol; 2000 Nov; 11(11):1285-8. PubMed ID: 11083251
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Comparison of basic electrical features of ICD defibrillating leads implanted to right ventricular apex or right ventricular outflow track and septum].
    Szafraniec Z; Kaczmarek K; Pałka K; Ptaszyński P; Ruta J; Chudzik M; Wranicz JK
    Pol Merkur Lekarski; 2014 Mar; 36(213):155-9. PubMed ID: 24779211
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined third-generation implantable cardioverter defibrillator with permanent unipolar pacemakers: preliminary observations.
    Haffajee C; Casavant D; Desai P; Moon R; Voukydis P; Pacetti P
    Pacing Clin Electrophysiol; 1996 Feb; 19(2):136-42. PubMed ID: 8834682
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Undetected ventricular fibrillation in transvenous implantable cardioverter-defibrillators. Prospective comparison of different lead system-device combinations.
    Natale A; Sra J; Axtell K; Akhtar M; Newby K; Kent V; Geiger MJ; Brandon MJ; Kearney MM; Pacifico A
    Circulation; 1996 Jan; 93(1):91-8. PubMed ID: 8616948
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ventricular oversensing: a study of 101 patients implanted with dual chamber defibrillators and two different lead systems.
    Weretka S; Michaelsen J; Becker R; Karle CA; Voss F; Hilbel T; Osswald BR; Bahner ML; Senges JC; Kuebler W; Schoels W
    Pacing Clin Electrophysiol; 2003 Jan; 26(1 Pt 1):65-70. PubMed ID: 12685142
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High incidence of diaphragmatic myopotential oversensing by a specific implantable cardioverter defibrillator.
    Baldinger SH; Haeberlin A; Servatius H; Seiler J; Noti F; Lam A; Sweda R; Reichlin T; Tanner H; Roten L
    Pacing Clin Electrophysiol; 2020 Feb; 43(2):234-239. PubMed ID: 31849077
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of signal analyses of ventricular tachycardia electrograms to predict the response of antitachycardia pacing in patients with implantable cardioverter-defibrillators.
    Tuan TC; Lo MT; Lin YJ; Hsieh WH; Lin C; Huang NE; Lo LW; Chao TF; Liao JN; Hsieh YC; Wu TJ; Chen SA
    J Cardiovasc Electrophysiol; 2014 Apr; 25(4):411-417. PubMed ID: 24320556
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The combined transvenous implantation of cardioverter defibrillators and permanent pacemakers.
    Mattke S; Markewitz A; Müller D; Grünewald A; Fiek M; Schmöckel M; Hoffmann E; Steinbeck G
    Pacing Clin Electrophysiol; 1997 Nov; 20(11):2775-82. PubMed ID: 9392808
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sensing/pacing lead complications with a newer generation implantable cardioverter-defibrillator: worldwide experience from the Guardian ATP 4210 clinical trial.
    Stambler BS; Wood MA; Damiano RJ; Greenway PS; Smutka ML; Ellenbogen KA
    J Am Coll Cardiol; 1994 Jan; 23(1):123-32. PubMed ID: 8277070
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of Inappropriate Shocks and Other Health Outcomes Between Single- and Dual-Chamber Implantable Cardioverter-Defibrillators for Primary Prevention of Sudden Cardiac Death: Results From the Cardiovascular Research Network Longitudinal Study of Implantable Cardioverter-Defibrillators.
    Peterson PN; Greenlee RT; Go AS; Magid DJ; Cassidy-Bushrow A; Garcia-Montilla R; Glenn KA; Gurwitz JH; Hammill SC; Hayes J; Kadish A; Reynolds K; Sharma P; Smith DH; Varosy PD; Vidaillet H; Zeng CX; Normand ST; Masoudi FA
    J Am Heart Assoc; 2017 Nov; 6(11):. PubMed ID: 29122811
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.